Both of VB Device’s developments have been selected for presentation at the 40th Charing Cross Meeting next April. CX is probably the most prestigious vascular meeting in Europe and the oldest specialty meeting. Both devices will be presented in the context of the congress’s Innovation Showcase.
Oliana, 27 | 08006 Barcelona | Spain
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 887677
Federico Grego has more than 20 years of experience in the pharmaceutical industry (LETI Pharma), in senior management positions, coupled with 4 years of experience in investment banking (HSBC). He also has extensive experience in the biomedical entrepreneurship sector helping to promote various projects, including Cytovation AS, Allero Therapeutics, and Nexkin Medical, among others. He is an economist (Tufts University), MBA (IESE) and AMP Certificate (Harvard).
